ÂÜÀòÂÒÂ×

Hsin-Yung (Jason) Yen is one of the founders of OMass Therapeutics and an advisor to the Company. After obtaining his PhD degree in glycobiology with Prof Chi-Huey Wong he became a post-doctoral scientist in Professor Dame Carol Robinson’s research group at the University of Oxford. Following his success in GPCR analysis with state-of-the-art mass spectrometry, he recorded the first mass spectrum of a folded GPCR with drug binding maintained. He invented a mass spectrometry platform that reports on compound efficacy on G proteins-/arrestins – coupling with receptors. Currently, he is a Principal Investigator at the Institute of Biological Chemistry, Academia Sinica in Taiwan, where he continues his research on technology development for intractable biology.